Tech Company Financing Transactions
Oncodesign Precision Medicine Funding Round
Oncodesign Precision Medicine, based in Dijon, secured investment capital from The Michael J. Fox Foundation for Parkinson's Research.
Transaction Overview
Company Name
Announced On
10/7/2026
Transaction Type
Debt
Amount
Unknown
Round
Undisclosed
Proceeds Purpose
This funding notably supports the manufacturing of the drug product required for the next stages of clinical development, as well as the long-term toxicology program for OPM-201.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
18 rue Jean Mazen
Dijon, 21000
France
Dijon, 21000
France
Phone
Website
Email Address
Overview
Our mission is to bring innovative therapeutic and diagnostic solutions to treat therapeutic resistance and metastasis evolution. The patient is at the centre of our reflexion, of our unique innovative model, and our investments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Philippe Genne
Browse more venture capital transactions:
Prev: 10/7/2026: Nous Research venture capital transaction
Next: 10/7/2026: MintNeuro venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs